To determine if anti-PAD2 antibodies were associated with specific serologic, genetic, or demographic characteristics within the RA population, patients were grouped according to their anti-PAD2 antibody status and variables collected at their baseline visit were compared (Table 1 and S1). This evidence concerns the gene PADI2 and rheumatoid arthritis.